全文获取类型
收费全文 | 14127篇 |
免费 | 898篇 |
国内免费 | 99篇 |
专业分类
耳鼻咽喉 | 157篇 |
儿科学 | 421篇 |
妇产科学 | 447篇 |
基础医学 | 1662篇 |
口腔科学 | 364篇 |
临床医学 | 1184篇 |
内科学 | 3200篇 |
皮肤病学 | 237篇 |
神经病学 | 769篇 |
特种医学 | 454篇 |
外国民族医学 | 6篇 |
外科学 | 2190篇 |
综合类 | 415篇 |
一般理论 | 8篇 |
预防医学 | 963篇 |
眼科学 | 420篇 |
药学 | 1231篇 |
中国医学 | 136篇 |
肿瘤学 | 860篇 |
出版年
2023年 | 174篇 |
2022年 | 426篇 |
2021年 | 603篇 |
2020年 | 396篇 |
2019年 | 512篇 |
2018年 | 578篇 |
2017年 | 399篇 |
2016年 | 407篇 |
2015年 | 391篇 |
2014年 | 590篇 |
2013年 | 719篇 |
2012年 | 1014篇 |
2011年 | 1051篇 |
2010年 | 630篇 |
2009年 | 513篇 |
2008年 | 760篇 |
2007年 | 777篇 |
2006年 | 673篇 |
2005年 | 681篇 |
2004年 | 586篇 |
2003年 | 498篇 |
2002年 | 447篇 |
2001年 | 223篇 |
2000年 | 203篇 |
1999年 | 218篇 |
1998年 | 90篇 |
1997年 | 67篇 |
1996年 | 62篇 |
1995年 | 74篇 |
1994年 | 63篇 |
1993年 | 51篇 |
1992年 | 96篇 |
1991年 | 83篇 |
1990年 | 102篇 |
1989年 | 83篇 |
1988年 | 82篇 |
1987年 | 79篇 |
1986年 | 85篇 |
1985年 | 65篇 |
1984年 | 54篇 |
1983年 | 35篇 |
1982年 | 37篇 |
1980年 | 32篇 |
1979年 | 42篇 |
1978年 | 31篇 |
1977年 | 31篇 |
1976年 | 33篇 |
1973年 | 26篇 |
1972年 | 24篇 |
1969年 | 30篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
The concentration of microsomal cytochromes P-450, and of protein in the homogenate, cytosol and microsomes were measured in the liver, kidney and duodenal mucosa of healthy well-fed male and female camels, sheep and goats. For comparison, data from the liver of male and female rats were also obtained. The protein concentrations in the tissues of adult animals were broadly similar in the four species. The concentration of cytochromes P-450 was highest in the liver, followed by the kidney, then the duodenal mucosa in all the species. No cytochromes P-450 were detected in the tissues of immature (less than 1 mo) male goats, whereas the female goat had the highest concentrations of these enzymes in the liver and kidney when compared with the respective tissues in the other species studied. Males had higher activity of cytochromes P-450 than females in the three tissues, except in the duodenal mucosa of sheep, where males had lower activity than females. In camel liver and sheep kidney, the amount of cytochromes P-450 were similar in the two sexes. The present results suggest that the mature female goat is the species best equipped to handle xenobiotics which are detoxified by the cytochromes P-450 and other drug metabolizing enzymes in diseased or malnourished animals is suggested as these two conditions are known to modify drug metabolizing enzymes. 相似文献
2.
Dipankar Nandi Helen Smith Sarah Owen Carole Joint John Stein Tipu Aziz 《Journal of clinical neuroscience》2002,9(5):557-561
Central post stroke pain is often difficult to manage satisfactorily with conventional treatment modalities for pain. In the last decade functional neurosurgery has offered hope with motor cortex stimulation achieving significant alleviation of pain in some patients. Unfortunately this has led to the neglect of chronic stimulation of deep grey matter as another modality of treating this condition. In this article we present our experience with motor cortex stimulation and that with deep grey matter stimulation in patients with post stroke pain. We argue that both modalities have a significant role and that what is required are better methods of identifying particular patients who are more likely to respond to one or the other. 相似文献
3.
4.
5.
Youness El harrech Hassan Jira Jaouad Chafiki Mohamed Ghadouane Ahmed Ameur Mohamed Abbar 《Actas urologicas espa?olas》2009,33(1):93-96
Nutcracker syndrome is caused by compression of the left renal vein between the aorta and the superior mesenteric artery where it passes in the fork formed at the bifurcation of these arteries. The phenomenon results in left renal venous hypertension. The syndrome is manifested by left flank and abdominal pain, with or without unilateral haematuria. The nutcracker syndrome has been treated in various ways. We report one case of the syndrome and discuss the place of surveillance in its management. 相似文献
6.
7.
Ruhangiz T. Kilani ; Larry Guilbert ; Xiaoyue Lin ; Aziz Ghahary 《Wound repair and regeneration》2007,15(2):236-244
Overexpression of wound healing-promoting factors such as transforming growth factor-1 (TGF-beta1) and insulin-like growth factor-1 (IGF-1) during the healing process has been implicated in the development of dermal fibrosis in patients following thermal injury, surgical incision, and deep trauma. However, the mechanism through which the expression of these two fibrogenic factors is slowed down and/or abrogated in the late stages of the healing process is not known. Here, we hypothesize that keratinocyte-releasable factors counteract the fibrogenic role of both IGF-1 and TGF-beta1 in fibroblasts. To test this hypothesis, the levels of collagenase (MMP-1), as an index for extracellular matrix degradation, in dermal fibroblasts in response to either keratinocyte-conditioned medium (KCM) or our recently identified keratinocyte-releasable stratifin in the presence and absence of either IGF-1, TGF-beta1, or both were evaluated. The results of Northern analysis showed a significant increase in collagenase mRNA expression in cells treated with KCM in the presence of both IGF-1 and TGF-beta1. The effect was, at least in part, due to keratinocyte-derived stratifin that was present in KCM. This was ascertained as the levels of MMP-1 mRNA were markedly reduced when cells were treated with stratifin-immuno-depleted KCM. The results of Western blot analysis showed an increase in the level of MMP-1 protein in stratifin-treated fibroblasts and this was consistent with the level of MMP-1 mRNA expression detected by Northern analysis. However, in contrast to KCM, whose efficacy on MMP-1 expression was modestly reduced by either IGF-1 and TGF-beta1, or a combination of both, these factors abrogated the MMP-1 stimulatory effect of stratifin in fibroblasts. In summary, the results of this study revealed that both stratifin and KCM stimulate the expression of MMP-1-in fibroblasts and this effect can be abrogated by either IGF-1, TGF-beta1, or a combination of both. 相似文献
8.
9.
Ali Akbar SALARI Shokouh TAGHIPOOR Hassan AMIR 《Asia-Pacific Journal of Clinical Oncology》2007,3(3):143-147
Aim: To investigate the clinico‐pathological profile and stage of disease at presentation of patients with carcinoma of the gallbladder diagnosed during 1992–2006 in Iran. Methods: During this study period 34 consecutive patients with gallbladder carcinoma were identified using a pathology‐based tumor database. The data extracted for each study patient included their gender, age at diagnosis, signs and symptoms, presence of gallstones and histopathological pattern of the gallbladder carcinoma and the UICC/AJCC TNM staging system was used for labeling the stages of the disease. Results: The median age of the 34 patients studied was 69.50 with most between 61 and 70 years of age. The age range of the men was between 53 and 80 years with a median age of 71.50 years and that of the women was between 33 and 79 years with a median age of 68.50 years. The most common symptom was pain in the right hypochondrium. More women had gallstones (15/34) than men (3/10). Adenocarcinoma was the most common histopathological type (91.18%) with the commonest subtype being papillary (47.06%). Eighteen patients had stage IB and stage IIA (52.94%) carcinomas whereas stages IIB and III were observed in six (17.6%) and seven cases (20.6%), respectively. Only three cases (8.82%) were seen in stage IV. The follow up of gall bladder carcinoma (GBC) patients in this study ranged from 6 to 60 months. However, there was a progressive reduction of patients attending follow‐up oncology clinic, particularly by those who had stages III and IV of the disease. Conclusion: Most patients (52.94%) presented with early disease (stage IB and IIA) which carries a good prognosis. Early detection of GBC and a national consensus for the evidence‐based management of GBC in Iran should be the major components of a strategy aimed at improving therapeutic outcome. 相似文献
10.
Mario von Depka Murtada Hassan Jan Blatn? Petr Smejkal Vladimir Vdovin 《Blood coagulation & fibrinolysis》2006,17(4):311-316
Spontaneous and surgery-associated bleeding in patients with von Willebrand disease (vWD) cannot always be controlled with desmopressin or replacement therapy. This paper presents results on the use of recombinant-activated factor VII (rFVIIa) in patients with vWD included in the internet registry Haemostasis.com. Twenty-eight reports on the use of rFVIIa in vWD were identified from the database and included in this analysis. The bleeding episodes were classified as mild (n = 7), moderate (n = 16), or severe (n = 2), and were unspecified in three cases. The median dose of rFVIIa administered was 94 microg/kg body weight (40-127.3 microg/kg). Bleeding stopped in 23 of 27 evaluable patients (85%) and markedly decreased in three patients; the total response rate was 96% (26/27 patients). Response did not correlate with the type of vWD, the site or severity of the initial bleed, or the rFVIIa dose. Other replacement therapies were infrequently used, and their use was similar in the 24 h before and after rFVIIa administration. Eighteen patients also received antifibrinolytic treatment, but its impact on response was not recorded. Only one adverse event (mild fever) was observed. These cases suggest a role for rFVIIa as a safe and effective therapy for vWD. 相似文献